Source:http://linkedlifedata.com/resource/pubmed/id/19040479
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2008-12-1
|
pubmed:abstractText |
Laboratory-based surveillance at a Finnish paediatric tertiary-care centre during the period 1999-2006 identified 739 nosocomial bloodstream infections (BSIs) (1.6 BSIs/1000 patient-days). High rates were detected among haematology patients (4.9 BSIs/1000 patient-days) and neonatology patients (3.2 BSIs/1000 patient-days). Most BSIs (95%) were primary infections, and 75% of those were associated with a central line. The most common pathogens were coagulase-negative staphylococci (52%), Staphylococcus aureus (7%) and Candida species (6%). The overall mortality rate within 7 days after the first positive blood culture was 3%. Those who died were more likely to have been admitted to an intensive-care unit or to have undergone surgery.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1469-0691
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1072-5
|
pubmed:meshHeading |
pubmed-meshheading:19040479-Adolescent,
pubmed-meshheading:19040479-Bacterial Infections,
pubmed-meshheading:19040479-Blood,
pubmed-meshheading:19040479-Child,
pubmed-meshheading:19040479-Cross Infection,
pubmed-meshheading:19040479-Finland,
pubmed-meshheading:19040479-Humans,
pubmed-meshheading:19040479-Infant, Newborn,
pubmed-meshheading:19040479-Intensive Care Units,
pubmed-meshheading:19040479-Mycoses,
pubmed-meshheading:19040479-Prevalence,
pubmed-meshheading:19040479-Risk Factors,
pubmed-meshheading:19040479-Sepsis
|
pubmed:year |
2008
|
pubmed:articleTitle |
Nosocomial bloodstream infections in children: an 8-year experience at a tertiary-care hospital in Finland.
|
pubmed:affiliation |
Department of Infectious Disease Epidemiology and Control, National Public Health Institute (KTL), Helsinki, Finland. emmi.sarvikivi@ktl.fi
|
pubmed:publicationType |
Journal Article
|